Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

WithdrawnOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
Complicated Skin and Skin Structure Infections and Bacteremia Including Right-sided Endocarditis
Trial Locations (5)

Unknown

Research Site, Lipa City

Research Site, Davao City

Research Site, Iloilo City

Research Site, Pasig

Research Site, Quezon City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY